Staar Surgical (Nasdaq:STAA) announced that it made a series of changes to realign its leadership structure to better address market needs. The shift atop the company comes around a month after the company laid off more than 100 workers amid challenging market conditions. Lake Forest, California–based Staar, a maker of Implantable Collamer lenses, created a […]
STAAR Surgical Co
Staar Surgical rises on Street-beating Q2, raised guidance
Staar Surgical (NSDQ:STAA) shares ticked up today on second-quarter results that topped the consensus forecast. The Lake Forest, Calif.-based implantable lens maker posted profits of $8.6 million, or 17¢ per share, on sales of $62.4 million for the three months ended July 2, 2021, for a massive bottom-line from over $1 million in the red […]
Staar Surgical rises on 44% sales growth in Q1 result
Staar Surgical (NSDQ:STAA) posted first-quarter results that beat the overall consensus on Wall Street. The Lake Forest, Calif.-based implantable eye lenses company yesterday reported profits of $4.99 million, or 10¢ per share, on sales of $50.75 million for the three months ended April 2, for a sales growth of 44.24% compared with Q1 2020. Adjusted to […]
Staar Surgical slides despite Street-beating Q4 results
Staar Surgical (NSDQ:STAA) posted fourth-quarter results yesterday that beat the consensus forecast on Wall Street. The Lake Forest, Calif.-based company reported profits of $3.3 million, or 7¢ per share, on sales of $46 million for the three months ended Jan. 1, 2021, for a bottom-line loss of -47.8% sales growth of 18.3% compared with Q4 2019. […]
Staar Surgical launches presbyopia correcting lens
Staar Surgical (NSDQ:STAA) announced today that it received CE Mark approval for its EVO Viva presbyiopia-correcting implantable Collamer lens (ICL). Lake Forest, Calif.-based Staar Surgical is launching the EVO Viva through select doctors in Spain, Germany and Belgium, initially, with broader availability set to follow across Europe and other markets recognizing the CE Mark, according to […]
Staar Surgical appoints CFO
Staar Surgical (NSDQ:STAA) today said it has appointed Patrick Williams as chief financial officer, effective immediately. Williams will report directly to the president and CEO Caren Mason. His appointment is part of a planned transition following Deborah Andrews’s retirement. “STAAR is pleased to have a financial leader of Patrick’s caliber join the team at a time […]
Staar Surgical beats on earnings, meets revenue in Q4 results
Staar Surgical (NSDQ:STAA) posted fourth-quarter results that beat the consensus forecast on Wall Street. The Monrovia, Calif.-based company reported profits of $6.4 million, or 14¢ per share, on sales of $38.9 million for the three months ended Jan. 3, 2020, for a bottom-line gain of 482% sales growth of 24.7% compared with Q4 2018. Adjusted to […]
Staar Surgical wins supplemental lens approval for Evo, Evo+, Visian
Staar Surgical (NSDQ:STAA) announced today that it won CE Mark approval for use of its three ICL lenses as supplemental lenses in post-cataract intraocular lenses surgery patients (pseudophakics). Lake Forest, Calif.-based Staar Surgical’s Evo, Evo+ and Visian lenses all earned the European approval. The Evo/Evo+ and Visian devices are implantable collamer lenses designed to treat myopia […]
FDA Oks Staar Surgical trial for Evo, Evo+ Visian lenses
Staar Surgical (NSDQ:STAA) said today that the FDA approved a U.S. clinical trial of its Evo and Evo+ Visian lenses. Monrovia, Calif.-based Staar’s Evo/Evo+ devices are implantable collamer lenses designed to treat myopia and myopia with astigmatism. In May, the FDA’s Center for Devices & Radiological Health requested more data on the lenses, claiming Staar lacked […]
Staar Surgical shares drop on FDA request for more data on EVO/EVO+ Visian lenses PMA bid
Staar Surgical (NSDQ:STAA) shares are down more than 10% after the company said it received a letter from the FDA’s Center for Devices and Radiological Health requesting more data for the premarket approval application supplement for its EVO/EVO+ Visian implantable collamer lenses for myopia and myopia with astigmatism. The federal watchdog said that the supplement lacked […]
Staar Surgical inks deal with Iberian eye clinic group
Staar Surgical (NSDQ:STAA) said today it inked a strategic cooperation agreement with ophthalmology clinic group Vista Oftalmólogos to offer its Evo Visian implantable collamer lenses for patients suffering from nearsightedness. Vista Oftalmólogos is a 49-clinic group across Spain, France, Portugal and Morocco and employs more than 200 eye doctors and has 1,000 employees, Monrovia, Calif.-based Staar […]
